How should we screen competitive athletes for cardiovascular disease?

Evolving Contemporary Management of Atrial Fibrillation in Hypertrophic Cardiomyopathy.

Circulation·2023

Analysis of risk stratification and prevention of sudden death in pediatric patients with hypertrophic cardiomyopathy: Dilemmas and clarity.

Heart rhythm O2·2023

Commotio Cordis Returns…When We Least Expected It: Cardiac Arrest in A Professional Football Player.

The American journal of cardiology·2023

Development of the Implantable Cardioverter-Defibrillator: JACC Historical Breakthroughs in Perspective.

Journal of the American College of Cardiology·2023

Do Implantable Cardioverter-Defibrillators Really Belong on the Athlete Field?

The American journal of cardiology·2023

Clinical Significance of Postoperative Atrial Fibrillation in Hypertrophic Cardiomyopathy Patients Undergoing Septal Myectomy.

The Canadian journal of cardiology·2023

Gender-related risk of myocardial infarction and subclinical coronary atherosclerosis: a Danish population cohort study.

European heart journal·2026

Oral anticoagulants, cognition, and clinical outcomes in atrial fibrillation and Alzheimer's disease: a Swedish nationwide study.

European heart journal·2026

Vitronectin-driven amyloid deposition disrupts mitochondrial homeostasis via integrin-mediated pathway in a humanized mouse model of transthyretin cardiac amyloidosis.

European heart journal·2026

RUNX1-driven endothelial-to-mesenchymal transition contributes to remodelling in LMNA cardiomyopathy.

European heart journal·2026

Endometriosis and long-term risk of venous thromboembolism: a Danish nationwide study.

European heart journal·2026

Temporal comparison of clinical practice and outcomes in heart failure: the JROADHF and JROADHF-NEXT studies.

European heart journal·2026

[Prevalencia de hepatitis B, hepatitis C y HTLV-1 mediante el uso del panel ampliado en mujeres embarazadas de dos ciudades de Colombia, 2024-2025].

Revista colombiana de obstetricia y ginecologia·2026

Clinical characteristics and outcomes of myocardial infarction, stroke, and cardiovascular mortality among patients undergoing complex high-risk indicated percutaneous coronary intervention: A one-year review in a single non-surgical centre.

The Medical journal of Malaysia·2026

Intravenous Nicorandil in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary PCI: The CLEAN Randomized Clinical Trial.

Journal of the American College of Cardiology·2026

Implications of the 2026 Versus 2018 ACC/AHA Multisociety Dyslipidemia Guidelines on the Clinical Care of U.S. Adults.

Journal of the American College of Cardiology·2026

Attendance Among People With Hepatitis B in UK Secondary Care: A Scoping Review.

Journal of viral hepatitis·2026

Related Experiment Videos

How should we screen competitive athletes for cardiovascular disease?

Related Concept Videos

Evolving Contemporary Management of Atrial Fibrillation in Hypertrophic Cardiomyopathy.

Analysis of risk stratification and prevention of sudden death in pediatric patients with hypertrophic cardiomyopathy: Dilemmas and clarity.

Commotio Cordis Returns…When We Least Expected It: Cardiac Arrest in A Professional Football Player.

Development of the Implantable Cardioverter-Defibrillator: JACC Historical Breakthroughs in Perspective.

Do Implantable Cardioverter-Defibrillators Really Belong on the Athlete Field?

Clinical Significance of Postoperative Atrial Fibrillation in Hypertrophic Cardiomyopathy Patients Undergoing Septal Myectomy.

Gender-related risk of myocardial infarction and subclinical coronary atherosclerosis: a Danish population cohort study.

Oral anticoagulants, cognition, and clinical outcomes in atrial fibrillation and Alzheimer's disease: a Swedish nationwide study.

Vitronectin-driven amyloid deposition disrupts mitochondrial homeostasis via integrin-mediated pathway in a humanized mouse model of transthyretin cardiac amyloidosis.

RUNX1-driven endothelial-to-mesenchymal transition contributes to remodelling in LMNA cardiomyopathy.

Endometriosis and long-term risk of venous thromboembolism: a Danish nationwide study.

Temporal comparison of clinical practice and outcomes in heart failure: the JROADHF and JROADHF-NEXT studies.

[Prevalencia de hepatitis B, hepatitis C y HTLV-1 mediante el uso del panel ampliado en mujeres embarazadas de dos ciudades de Colombia, 2024-2025].

Clinical characteristics and outcomes of myocardial infarction, stroke, and cardiovascular mortality among patients undergoing complex high-risk indicated percutaneous coronary intervention: A one-year review in a single non-surgical centre.

Intravenous Nicorandil in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary PCI: The CLEAN Randomized Clinical Trial.

Implications of the 2026 Versus 2018 ACC/AHA Multisociety Dyslipidemia Guidelines on the Clinical Care of U.S. Adults.

Attendance Among People With Hepatitis B in UK Secondary Care: A Scoping Review.

Related Experiment Videos

How should we screen competitive athletes for cardiovascular disease?

Related Concept Videos

Related Articles